Skip to main content
JIUZHITANG CO.,LTD logo

JIUZHITANG CO.,LTD — Investor Relations & Filings

Ticker · 000989 ISIN · CNE000001394 LEI · 3003004OFW6FCZ34KN72 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,885 across all filing types
Latest filing 2023-08-07 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000989

About JIUZHITANG CO.,LTD

https://www.hnjzt.com

JIUZHITANG CO.,LTD. is a pharmaceutical enterprise specializing in the research, development, manufacturing, and distribution of Traditional Chinese Medicine (TCM). Established in 1650, the company is recognized as a time-honored brand with a heritage spanning over three centuries. Its core product portfolio includes a diverse range of TCM formulations, most notably Liuwei Dihuang Wan, donkey-hide gelatin (Ejiao), and various health supplements focused on chronic disease management and general wellness. The company operates modern production facilities that integrate traditional processing techniques with contemporary scientific standards and biotechnology. JIUZHITANG focuses on the modernization of TCM through clinical research and innovation, maintaining a distribution network that serves retail pharmacies and medical institutions to provide natural healthcare solutions.

Recent filings

Filing Released Lang Actions
独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和独立意见
Audit Report / Information Classification · 90% confidence The document is a special statement and independent opinion by the independent directors of the company regarding related party transactions and external guarantees. It references regulatory rules from the China Securities Regulatory Commission and Shenzhen Stock Exchange, focusing on compliance and risk control related to funds and guarantees. The content is a formal declaration and opinion rather than a full audit report or annual report. It does not contain financial statements or detailed audit results but is a regulatory compliance disclosure related to governance and risk management. This fits best under Audit Report / Information (AR), which includes standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests, excluding full annual reports. The document length is short but contains substantive content beyond a mere announcement, so it is not RPA or RNS. Therefore, the classification is AR with high confidence. FY 2023
2023-08-07 Chinese
第八届监事会第十一次会议监事书面审核意见
Regulatory Filings Classification · 95% confidence The document is a short announcement containing the supervisory board's written review opinion on the company's 2023 semi-annual report. It states that the supervisory board has audited and approved the half-year report's preparation and content. The document length is only 372 characters, indicating it is not the full semi-annual report but rather an official statement or certification regarding the report. According to the rules, such a short document that certifies or attests to a report without containing substantive financial data should be classified as a Regulatory Filing (RNS).
2023-08-07 Chinese
2023年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '九芝堂股份有限公司2023 年半年度报告全文' which translates to 'Jiuzhitang Co., Ltd. 2023 Semi-Annual Report Full Text'. It includes detailed financial data for the period January 1, 2023 to June 30, 2023, management discussion and analysis, company overview, business segments, financial indicators, and other comprehensive information typical of an interim or quarterly report. The document length is about 15,000 characters, indicating a full report rather than a brief announcement. The content includes actual financial statements, performance analysis, and operational details for the half-year period, which matches the definition of an Interim / Quarterly Report (IR). There is no indication that this is an announcement of a report or a certification document, so it is not RPA or RNS. Therefore, the document is classified as an Interim / Quarterly Report (IR). H1 2023
2023-08-07 Chinese
半年度非经营性资金占用及其他关联资金往来情况汇总表
Interim / Quarterly Report Classification · 90% confidence The document is a summary table of non-operating fund occupation and other related party fund transactions for the half-year period of 2023 by 九芝堂股份有限公司. It contains detailed financial data on balances, transactions, and related party relationships for the six-month period ending June 30, 2023. The presence of half-year period data and substantive financial figures indicates this is a financial report for a period shorter than a full fiscal year. The document is not an announcement or a brief summary but a detailed financial disclosure. Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length is 1438 characters, which is relatively short but contains actual financial data and analysis, supporting classification as IR rather than a report publication announcement or regulatory filing. H1 2023
2023-08-07 Chinese
2023年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "九芝堂股份有限公司2023 年半年度财务报告" which translates to "Jiuzhitang Co., Ltd. 2023 Semi-Annual Financial Report." It contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and changes in equity for the half-year period ending June 30, 2023. The document explicitly states it is a semi-annual report and includes comprehensive financial data and analysis for the period. It is not an announcement or a brief summary but a full financial report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2023
2023-08-07 Chinese
关于控股股东部分股份质押及解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the pledge and release of shares by a controlling shareholder of the company 九芝堂股份有限公司. It details the number of shares pledged, released, and the associated risks, but does not contain financial statements or detailed financial performance data. The document is relatively short (1840 characters) and focuses on share pledge information rather than financial results or management discussion. This fits the category of a Regulatory Filing (RNS) as it is a regulatory disclosure about share pledging activities and risk, not a full financial report or earnings release.
2023-07-04 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.